Decision-Making Involvement for Young Adults with Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how young adults with cancer prefer to make treatment decisions. Participants will answer questions about various treatment scenarios to determine their desired level of involvement from healthcare providers, family, and friends. The goal is to identify factors that help or hinder shared decision-making between patients and their support networks. This trial is open to individuals aged 15-29 who have been diagnosed with cancer, are currently in treatment, and can communicate in English. As an unphased trial, it offers a unique opportunity for participants to contribute to improving decision-making processes for young cancer patients.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on decision-making preferences for young adults with cancer.
What prior data suggests that this method is safe for assessing decision-making preferences in young adults with cancer?
Previous studies have examined how young adults with cancer decide on their treatment, focusing on the level of control and involvement they desire in making these choices. The research aimed to understand their preferences rather than test a new drug or medical device.
As this study centers on decision-making and preferences, it does not present safety concerns typical of drug trials. It involves collecting information on how young adults wish to engage in their care. This type of study is very safe, as it only involves answering questions and discussing decisions, without administering any treatment or medication.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on understanding how young adults with cancer prefer to make decisions about their treatment. Unlike standard approaches that often prioritize medical perspectives, this trial highlights the importance of involving patients in the decision-making process alongside healthcare providers and family. By examining how these young patients want to participate in their care, the study aims to uncover barriers and facilitators to shared decision-making, ultimately paving the way for more personalized and patient-centered cancer care.
What evidence suggests that this decision-making assessment is effective for understanding young adults' preferences in cancer treatment decisions?
Research has shown that when teenagers and young adults (AYAs) participate in decisions about their cancer treatment, outcomes can improve. In this trial, participants will engage in the AYA Decision-Making Role Assessment, which involves completing an electronic socio-demographic questionnaire and responding to hypothetical clinical decision-making scenarios. Studies indicate that 58% of AYAs prefer to share decision-making with their doctors. This collaboration often increases their satisfaction and involvement in their treatment. Additionally, including AYAs in these decisions aligns with patient- and family-centered care practices, which are known to have positive effects. Overall, involving AYAs in decision-making helps tailor their care to fit their preferences and needs, leading to more personalized and effective treatments.46789
Who Is on the Research Team?
Kimberly Pyke-Grimm
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for Adolescents and Young Adults (AYAs) who have been diagnosed with cancer. It aims to understand their preferences in making decisions about their treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants complete an electronic socio-demographic questionnaire and hypothetical clinical decision-making scenarios
Follow-up
Participants' decision-making roles are assessed through interviews and healthcare encounter analysis
What Are the Treatments Tested in This Trial?
Interventions
- Clinical Decision-Making Scenarios and Preferences Assessment
Trial Overview
The study uses clinical scenarios and assessments to explore how AYAs want to be involved in decision-making post-cancer diagnosis, examining factors that influence these preferences.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will complete an electronic socio-demographic questionnaire followed by a set of hypothetical clinical decision-making scenarios to assess preferred decision-making roles and involvement of healthcare providers and family/friends. Responses will inform understanding of facilitators and barriers to shared decision-making.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Citations
Cancer-Related Decision-Making Among Adolescents, Young ...
Decision-making among adolescents and young adults with cancer (AYA) is often complex, ongoing, and multifaceted, involving caregiver and oncology provider ...
Treatment Decision-Making Involvement in Adolescents and ...
Involvement in treatment decision making (TDM) is considered a key element of patient- and family-centered care and positively impacts outcomes.
3.
journals.sagepub.com
journals.sagepub.com/doi/10.1089/jayao.2018.0116?int.sj-abstract.similar-articles.1Identifying and Quantifying Adolescent and Young Adult ...
Identifying and Quantifying Adolescent and Young Adult Patient Preferences in Cancer Care: Development of a Conjoint Analysis-Based Decision-Making Tool.
4.
researchgate.net
researchgate.net/publication/332517325_Adolescent_and_Young_Adult_Cancer_Patients'_Experiences_With_Treatment_Decision-makingAdolescent and Young Adult Cancer Patients' Experiences ...
Results: A majority of AYAs (58%) wanted to share responsibility for decision-making with oncologists; half (51%) preferred limited involvement from parents.
Their Preferred Involvement in Decision Making
This outcome measures the correlation between the number of cancer-related healthcare encounters and adolescents' and young adults' preferred treatment decision ...
Exploration of Decisional Control Preferences in Adolescents ...
This study describes the degree of decisional control AYA patients preferred in complex medical decisions.
A mixed methods systematic review
To examine the experiences and perspectives regarding developmentally appropriate cancer services for adolescents and young adults with cancer.
Day-to-Day Decision Making by Adolescents and Young ...
Exploration of decisional control preferences in adolescents and young adults with cancer and other complex medical conditions. Journal of ...
9.
ctv.veeva.com
ctv.veeva.com/study/adolescents-and-young-adults-with-cancer-their-preferred-involvement-in-decision-makingTheir Preferred Involvement in Decision Making
The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.